BioSpace News Archive

Promega Corporation announced the opening of Kornberg Center, the biotech company’s newly constructed research and development facility on its Fitchburg, WI campus.

Ribon Therapeutics, a clinical stage oncology company developing therapeutics targeting stress support pathways, today announced that it will present one oral and four poster presentations at the American Association for Cancer Research (AACR) 2021 Virtual Annual Meeting (Week 1), taking place from April 10 to 15, 2021. Abstracts are available at: www.aacr.org .

Pinteon Therapeutics, a biotechnology company focused on protecting neuronal health by targeting neurotoxic forms of tau, today announced that the first patient has been dosed in a Phase 1b multiple ascending dose study evaluating PNT001, a novel tau antibody that uniquely targets a toxic epitope known to drive neurodegenerative disease, in patients with acute traumatic brain injury (TBI).

AVROBIO, Inc., a leading clinical-stage gene therapy company with a mission to free people from a lifetime of genetic disease, announced that the company has granted non-statutory stock options for the purchase of up to an aggregate of 140,000 shares of the company’s common stock to 10 new employees as inducement awards under the company’s 2019 Inducement Plan.

AstraZeneca - Heart failure and asthma studies will pilot a new digital health platform to help improve outcomes for patients with chronic diseases

Overland ADCT BioPharma, a joint venture created by Overland Pharmaceuticals and ADC Therapeutics SA (NYSE: ADCT), today announced the appointment of Eric Koo, BSc, MBA, as Chief Executive Officer.

Company founded by Polaris Partners with latest financing led by Vida Ventures Funding will support advancement of novel approaches to predict and target metastasis, one of the biggest unsolved challenges in cancer

- Data further demonstrate proof-of-concept for the therapeutic potential of apitegromab in patients with Type 2 and Type 3 SMA - Phase 3 registrational trial initiation expected by the end of 2021 - European Medicines Agency (EMA) granted Priority Medicines (PRIME) designation to apitegromab, recognizing unmet medical needs of patients with SMA

Strategic acquisition of German fluorescence-guided surgery leader drives growth of Erbe’s surgical endoscopy business

Drs. Mircea Ivan, David Rubin and Patrick Farmer join Penrose’s growing board of experts in latest round of scientific appointees